In the past week, EXAS stock has gone up by 13.38%, with a monthly gain of 22.39% and a quarterly plunge of -7.01%. The volatility ratio for the week is 4.32%, and the volatility levels for the last 30 days are 4.56% for Exact Sciences Corp. The simple moving average for the last 20 days is 14.85% for EXAS’s stock, with a simple moving average of -3.21% for the last 200 days.
Is It Worth Investing in Exact Sciences Corp. (NASDAQ: EXAS) Right Now?
Moreover, the 36-month beta value for EXAS is 1.25. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 5 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for EXAS is 179.64M and currently, short sellers hold a 3.63% of that float. On April 02, 2024, EXAS’s average trading volume was 2.02M shares.
EXAS) stock’s latest price update
Exact Sciences Corp. (NASDAQ: EXAS) has experienced a rise in its stock price by 1.95 compared to its previous closing price of 69.06. However, the company has seen a gain of 13.38% in its stock price over the last five trading days. Zacks Investment Research reported 2024-03-26 that Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Analysts’ Opinion of EXAS
Many brokerage firms have already submitted their reports for EXAS stocks, with The Benchmark Company repeating the rating for EXAS by listing it as a “Buy.” The predicted price for EXAS in the upcoming period, according to The Benchmark Company is $91 based on the research report published on January 02, 2024 of the current year 2024.
Guggenheim, on the other hand, stated in their research note that they expect to see EXAS reach a price target of $90. The rating they have provided for EXAS stocks is “Buy” according to the report published on December 14th, 2023.
Wolfe Research gave a rating of “Outperform” to EXAS, setting the target price at $95 in the report published on December 13th of the previous year.
EXAS Trading at 13.77% from the 50-Day Moving Average
After a stumble in the market that brought EXAS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -30.13% of loss for the given period.
Volatility was left at 4.56%, however, over the last 30 days, the volatility rate increased by 4.32%, as shares surge +18.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.99% upper at present.
During the last 5 trading sessions, EXAS rose by +13.38%, which changed the moving average for the period of 200-days by -24.75% in comparison to the 20-day moving average, which settled at $61.85. In addition, Exact Sciences Corp. saw -4.83% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EXAS starting from Condella Sarah, who sale 2,000 shares at the price of $70.00 back on Mar 28 ’24. After this action, Condella Sarah now owns 73,787 shares of Exact Sciences Corp., valued at $140,000 using the latest closing price.
Conroy Kevin T, the President and CEO of Exact Sciences Corp., sale 8,271 shares at $59.32 during a trade that took place back on Mar 01 ’24, which means that Conroy Kevin T is holding 1,299,496 shares at $490,636 based on the most recent closing price.
Stock Fundamentals for EXAS
Current profitability levels for the company are sitting at:
- -0.09 for the present operating margin
- 0.74 for the gross margin
The net margin for Exact Sciences Corp. stands at -0.08. The total capital return value is set at -0.04. Equity return is now at value -6.60, with -3.00 for asset returns.
Based on Exact Sciences Corp. (EXAS), the company’s capital structure generated 0.45 points at debt to capital in total, while cash flow to debt ratio is standing at 0.06. The debt to equity ratio resting at 0.81. The interest coverage ratio of the stock is -8.39.
Currently, EBITDA for the company is -13.13 million with net debt to EBITDA at -20.93. When we switch over and look at the enterprise to sales, we see a ratio of 5.89. The receivables turnover for the company is 12.28for trailing twelve months and the total asset turnover is 0.39. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.32.
Conclusion
To wrap up, the performance of Exact Sciences Corp. (EXAS) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
